异动解读 | 莫德纳公司盘中股价大涨5.12%,反映市场对其疫苗及业务前景的看好

异动解读
31 Dec 2024

莫德纳(MRNA)公司今日盘中股价大涨5.12%,引发了市场的广泛关注。

作为首家获批的Covid-19疫苗生产商,莫德纳的mRNA技术已经在疫苗领域获得了成功应用。而近期市场人士预期,该公司在传染病、癌症和罕见病等其他疾病领域也可能凭借mRNA平台技术取得进展,从而推动其长期业务增长。

据公开资料,莫德纳目前有40个基于mRNA平台的药物处于临床试验阶段,覆盖多个重点治疗领域。投资者对其广阔的管线和潜在发展前景持乐观态度,也可能推动了股价的上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10